• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

形态学特征分析与免疫组化联合应用有助于筛选 EML4-ALK 阳性肺腺癌。

Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma.

机构信息

Department of Pathology, Osaka Police Hospital, Tennouji-ku, Osaka, Japan.

出版信息

J Clin Pathol. 2010 Dec;63(12):1066-70. doi: 10.1136/jcp.2010.081166. Epub 2010 Oct 9.

DOI:10.1136/jcp.2010.081166
PMID:20935334
Abstract

BACKGROUND

A subset of lung cancers harbours the fusion gene echinoderm microtubule-associated protein-like-4-anaplastic lymphoma kinase (EML4-ALK). Recently, immunohistochemistry for ALK has shown sensitivity for the detection of EML4-ALK-positive lung adenocarcinoma almost equal to that of the fluorescence in situ hybridisation (FISH) assay.

AIMS

To study the clinicopathological features of EML4-ALK-positive lung adenocarcinoma in a large number of surgically resected samples using immunohistochemistry, in order to establish a useful screening method for EML4-ALK-positive lung adenocarcinoma.

METHODS

Immunohistochemistry for ALK was used to screen for EML4-ALK-positive lung adenocarcinomas in 254 cases of surgically resected samples.

RESULTS

EML4-ALK-positive cases were detected in 3.1% of lung adenocarcinomas (8/254). EML4-ALK-positive lung adenocarcinomas showed significant associations with intra- and/or extra-cytoplasmic mucin (p=0.0001), and cribriform pattern with excessive extracytoplasmic mucin (p<0.0001). Signet-ring cell appearance alone lacked significance (p=0.149).

CONCLUSION

EML4-ALK-positive lung adenocarcinoma has a tendency to express a characteristic morphological pattern. The combined use of morphological feature analysis and immunohistochemistry may be a useful and cost effective screening method for EML4-ALK lung adenocarcinoma.

摘要

背景

一部分肺癌存在棘皮动物微管相关蛋白样-4-间变性淋巴瘤激酶(EML4-ALK)融合基因。最近,免疫组织化学ALK 检测显示出对 EML4-ALK 阳性肺腺癌的敏感性,几乎与荧光原位杂交(FISH)检测相当。

目的

通过免疫组织化学方法研究大量手术切除样本中 EML4-ALK 阳性肺腺癌的临床病理特征,以建立一种用于 EML4-ALK 阳性肺腺癌的有用筛查方法。

方法

使用免疫组织化学方法对 254 例手术切除样本进行 ALK 检测,以筛选 EML4-ALK 阳性肺腺癌。

结果

在 3.1%(8/254)的肺腺癌中检测到 EML4-ALK 阳性病例。EML4-ALK 阳性肺腺癌与细胞内和/或细胞外黏蛋白(p=0.0001)以及伴有过多细胞外黏蛋白的筛状模式(p<0.0001)显著相关。单纯印戒细胞外观无显著意义(p=0.149)。

结论

EML4-ALK 阳性肺腺癌具有表达特征性形态模式的趋势。形态特征分析与免疫组织化学相结合可能是一种有用且具有成本效益的 EML4-ALK 肺腺癌筛查方法。

相似文献

1
Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma.形态学特征分析与免疫组化联合应用有助于筛选 EML4-ALK 阳性肺腺癌。
J Clin Pathol. 2010 Dec;63(12):1066-70. doi: 10.1136/jcp.2010.081166. Epub 2010 Oct 9.
2
Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.反转录-聚合酶链反应、免疫组织化学和荧光原位杂交方法检测棘皮动物微管相关蛋白样 4-间变性淋巴瘤激酶融合阳性非小细胞肺癌的比较:对最佳临床检测的影响。
Arch Pathol Lab Med. 2012 Jul;136(7):796-803. doi: 10.5858/arpa.2011-0321-OA.
3
Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.间变性淋巴瘤激酶免疫反应性与非小细胞肺癌中的ALK基因重排及转录上调相关。
Hum Pathol. 2009 Aug;40(8):1152-8. doi: 10.1016/j.humpath.2009.01.012. Epub 2009 Apr 22.
4
Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.外显子数组分析在乳腺癌、结直肠癌和非小细胞肺癌中检测到 EML4-ALK 融合。
Mol Cancer Res. 2009 Sep;7(9):1466-76. doi: 10.1158/1541-7786.MCR-08-0522. Epub 2009 Sep 8.
5
Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer.通过逆转录聚合酶链反应进行外显子扫描以检测非小细胞肺癌中已知和新型的EML4-ALK融合变体
Cancer Genet. 2011 Jan;204(1):45-52. doi: 10.1016/j.cancergencyto.2010.08.024.
6
EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas.在非小细胞肺癌中存在EML4-ALK融合转录本,但不存在NPM-、TPM3-、CLTC-、ATIC-或TFG-ALK融合转录本。
Lung Cancer. 2008 Aug;61(2):163-9. doi: 10.1016/j.lungcan.2007.12.013. Epub 2008 Feb 1.
7
Bright-field dual-color chromogenic in situ hybridization for diagnosing echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinomas.用于诊断棘皮动物微管相关蛋白样 4-间变性淋巴瘤激酶阳性肺腺癌的明场双色显色原位杂交。
J Thorac Oncol. 2011 Oct;6(10):1677-86. doi: 10.1097/JTO.0b013e3182286d25.
8
Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: a novel ALK fusion gene?具有间变性淋巴瘤激酶免疫反应性的小细胞非黏液性细支气管肺泡癌:一种新型的 ALK 融合基因?
Cancer Sci. 2012 Feb;103(2):390-2. doi: 10.1111/j.1349-7006.2011.02136.x.
9
Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods.采用荧光原位杂交(FISH)、免疫组织化学(IHC)和逆转录聚合酶链反应(RT-PCR)方法,利用胸腔积液检测肺腺癌中的EML4-ALK。
PLoS One. 2015 Mar 18;10(3):e0117032. doi: 10.1371/journal.pone.0117032. eCollection 2015.
10
Detection of ALK fusion in lung cancer using fluorescence in situ hybridization.使用荧光原位杂交技术检测肺癌中的ALK融合
Asian Cardiovasc Thorac Ann. 2012 Aug;20(4):426-31. doi: 10.1177/0218492312440700.

引用本文的文献

1
Spread Through Air Spaces (STAS) as a Predictive and Prognostic Factor in Patients with Non-Small Cell Lung Cancer-Systematic Review.气腔播散(STAS)作为非小细胞肺癌患者的预测和预后因素——系统评价
Cancers (Basel). 2025 May 18;17(10):1696. doi: 10.3390/cancers17101696.
2
The presence of a cribriform pattern is related to poor prognosis in lung adenocarcinoma after surgical resection: A meta-analysis.筛状模式的存在与肺腺癌手术后预后不良相关:一项荟萃分析。
Gen Thorac Cardiovasc Surg. 2024 Sep;72(9):553-561. doi: 10.1007/s11748-024-02044-8. Epub 2024 May 27.
3
Clinicopathological features and prognostic significance of pulmonary adenocarcinoma with signet ring cell components: meta-analysis and SEER analysis.
具有印戒细胞成分的肺腺癌的临床病理特征及预后意义:荟萃分析和 SEER 分析。
Clin Exp Med. 2023 Dec;23(8):4341-4354. doi: 10.1007/s10238-023-01200-3. Epub 2023 Oct 1.
4
Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumoral Heterogeneity.空间分辨蛋白质组学和转录组学分析间变性淋巴瘤激酶重排肺腺癌揭示了肿瘤内和肿瘤间异质性的关键因素。
Int J Mol Sci. 2023 Jul 12;24(14):11369. doi: 10.3390/ijms241411369.
5
Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study.ALK 重排阳性非小细胞肺癌中的动脉和静脉血栓栓塞:一项基于人群的队列研究。
Oncologist. 2023 Jun 2;28(6):e391-e396. doi: 10.1093/oncolo/oyad061.
6
Current status and perspectives of spread through air spaces in lung cancer.肺癌空气传播途径的现状与展望。
Thorac Cancer. 2021 Jun;12(11):1639-1646. doi: 10.1111/1759-7714.13918. Epub 2021 May 5.
7
Copy Number Variation and Rearrangements Assessment in Cancer: Comparison of Droplet Digital PCR with the Current Approaches.癌症中拷贝数变异和重排的评估:液滴数字 PCR 与现行方法的比较。
Int J Mol Sci. 2021 Apr 29;22(9):4732. doi: 10.3390/ijms22094732.
8
Signet-ring Cell Carcinoma Component as an Indicator of Anaplastic Lymphoma Kinase Mutations in Colorectal Cancer.印戒细胞癌成分作为结直肠癌中间变性淋巴瘤激酶突变的一个指标
J Anus Rectum Colon. 2021 Apr 28;5(2):167-172. doi: 10.23922/jarc.2020-068. eCollection 2021.
9
CT features and disease spread patterns in ROS1-rearranged lung adenocarcinomas: comparison with those of EGFR-mutant or ALK-rearranged lung adenocarcinomas.ROS1 重排肺腺癌的 CT 特征和疾病扩散模式:与 EGFR 突变或 ALK 重排肺腺癌的比较。
Sci Rep. 2020 Oct 1;10(1):16251. doi: 10.1038/s41598-020-73533-y.
10
CT Characteristics of Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangement: A Systematic Review and Meta-Analysis.CT 特征在间变性淋巴瘤激酶重排非小细胞肺癌中的作用:系统评价和荟萃分析。
AJR Am J Roentgenol. 2019 Nov;213(5):1059-1072. doi: 10.2214/AJR.19.21485. Epub 2019 Aug 15.